Skip to Content

Notice

Importer of Controlled Substances Application: United States Pharmacopeial Convention

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 21, 2019. Such persons may also file a written request for a hearing on the application on or before June 21, 2019.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.34(a), this is notice that on March 8, 2019, United States Pharmacopeial, 12601 Twinbrook Parkway, Rockville, Maryland 20852-1717 applied to be registered as an importer of the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
Methamphetamine1105II
Cathinone1235I
Phenmetrazine1631II
Methylphenidate1724II
Amobarbital2125II
Pentobarbital2270II
Secobarbital2315II
Glutethimide2550II
Methaqualone2565I
Lysergic acid diethylamide7315I
4-Methyl-2,5-dimethoxyamphetamine7395I
3,4-Methylenedioxyamphetamine7400I
4-Methoxyamphetamine7411I
Phencyclidine7471II
4-Anilino-N-phenethyl-4-piperidine (ANPP)8333II
Phenylacetone8501II
Alphaprodine9010II
Anileridine9020II
Cocaine9041II
Codeine-N-oxide9053I
Dihydrocodeine9120II
Difenoxin9168I
Diphenoxylate9170II
Heroin9200I
Levomethorphan9210II
Levorphanol9220II
Meperidine9230II
Dextropropoxyphene, bulk (non-dosage forms)9273II
Start Printed Page 23583
Morphine-N-oxide9307I
Thebaine9333II
Norlevorphanol9634II
Oxymorphone9652II
Noroxymorphone9668II
Alfentanil9737II
Sufentanil9740II

The company plans to import the bulk control substances for distribution of analytical reference standards to its customers for analytical testing of raw materials.

Start Signature

Dated: May 7, 2019.

John J. Martin,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-10668 Filed 5-21-19; 8:45 am]

BILLING CODE 4410-09-P